Printer Friendly

Swedish biotech company Vitrolife AB takes over marketing and sales of its fertility media in France.

NORDIC BUSINESS REPORT-6 February 2008-Swedish biotech company Vitrolife AB takes over marketing and sales of its fertility media in France(C)1994-2008 M2 COMMUNICATIONS LTD

Swedish biotech company Vitrolife AB said on Tuesday (5 February) that it has decided to end its fertility media sales and distribution agreement with the French company JCD SAS and to begin direct sales in the French market.

The marketing and sales of Vitrolife's fertility media will be taken over by Vitrolife's French branch, which already sells the company's instrument products in France.

"This is in line with Vitrolife's strategy to use its own organisation in key markets and gives the company the opportunity to be more aggressive and increase its market share in the French market," Vitrolife said.

Vitrolife, headquartered in Kungsbacka, Sweden, develops and manufactures biotechnology products and medical devices for the preparation, cultivation and storage of human cells, tissue and organs. The company has 140 employees in Sweden and the US. Vitrolife is listed on the Nordic alternative market First North.

((Comments on this story may be sent to

COPYRIGHT 2008 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Date:Feb 6, 2008
Previous Article:Finnair Plc reports operating profit and turnover up in 2007.
Next Article:Sweden's CashGuard AB signs sales agreement for British market with 360Cash.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters